» Articles » PMID: 17443311

Association Testing of Common Variants in the Insulin Receptor Substrate-1 Gene (IRS1) with Type 2 Diabetes

Overview
Journal Diabetologia
Specialty Endocrinology
Date 2007 Apr 20
PMID 17443311
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aims/hypothesis: Activation of the insulin receptor substrate-1 (IRS1) is a key initial step in the insulin signalling pathway. Despite several reports of association of the G972R polymorphism in its gene IRS1 with type 2 diabetes, we and others have not observed this association in well-powered samples. However, other nearby variants might account for the putative association signal.

Subjects And Methods: We characterised the haplotype map of IRS1 and selected 20 markers designed to capture common variations in the region. We genotyped this comprehensive set of markers in several family-based and case-control samples of European descent totalling 12,129 subjects.

Results: In an initial sample of 2,235 North American and Polish case-control pairs, the minor allele of the rs934167 polymorphism showed nominal evidence of association with type 2 diabetes (odds ratio [OR] 1.25, 95% CI 1.03-1.51, p = 0.03). This association showed a trend in the same direction in 7,659 Scandinavian samples (OR 1.16, 95% CI 0.96-1.39, p = 0.059). The combined OR was 1.20 (p = 0.008), but statistical correction for the number of variants examined yielded a p value of 0.086. We detected no differences across rs934167 genotypes in insulin-related quantitative traits.

Conclusions/interpretation: Our data do not support an association of common variants in IRS1 with type 2 diabetes in populations of European descent.

Citing Articles

S-Klotho level and physiological markers of cardiometabolic risk in healthy adult men.

Zelazniewicz A, Nowak-Kornicka J, Pawlowski B Aging (Albany NY). 2022; 14(2):708-727.

PMID: 35093938 PMC: 8833136. DOI: 10.18632/aging.203861.


Insulin receptor substrate 1 (IRS1) variants confer risk of diabetes in the Boston Puerto Rican Health Study.

Feng X, Tucker K, Parnell L, Shen J, Lee Y, Ordovas J Asia Pac J Clin Nutr. 2013; 22(1):150-9.

PMID: 23353623 PMC: 4428925. DOI: 10.6133/apjcn.2013.22.1.09.


Genetic association analysis of LARS2 with type 2 diabetes.

Reiling E, Jafar-Mohammadi B, van t Riet E, Weedon M, van Vliet-Ostaptchouk J, Hansen T Diabetologia. 2009; 53(1):103-10.

PMID: 19847392 PMC: 2789927. DOI: 10.1007/s00125-009-1557-7.


Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia.

Rung J, Cauchi S, Albrechtsen A, Shen L, Rocheleau G, Cavalcanti-Proenca C Nat Genet. 2009; 41(10):1110-5.

PMID: 19734900 DOI: 10.1038/ng.443.

References
1.
Sun M, Lee J, de Bakker P, Burtt N, Almgren P, Rastam L . Haplotype structures and large-scale association testing of the 5' AMP-activated protein kinase genes PRKAA2, PRKAB1, and PRKAB2 [corrected] with type 2 diabetes. Diabetes. 2006; 55(3):849-55. DOI: 10.2337/diabetes.55.03.06.db05-1418. View

2.
Florez J, Sjogren M, Burtt N, Orho-Melander M, Schayer S, Sun M . Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetes. Diabetes. 2004; 53(12):3313-8. DOI: 10.2337/diabetes.53.12.3313. View

3.
Reis I, Hirji K, Afifi A . Exact and asymptotic tests for homogeneity in several 2 x 2 tables. Stat Med. 1999; 18(8):893-906. DOI: 10.1002/(sici)1097-0258(19990430)18:8<893::aid-sim84>3.0.co;2-5. View

4.
de Bakker P, Yelensky R, Peer I, Gabriel S, Daly M, Altshuler D . Efficiency and power in genetic association studies. Nat Genet. 2005; 37(11):1217-23. DOI: 10.1038/ng1669. View

5.
Boehnke M, Langefeld C . Genetic association mapping based on discordant sib pairs: the discordant-alleles test. Am J Hum Genet. 1998; 62(4):950-61. PMC: 1377027. DOI: 10.1086/301787. View